Stockscreener 앱 받기
20.88
7.19%
1.40
시간 외 거래:
21.17
0.29
+1.39%
전일 마감가:
$19.48
열려 있는:
$19.6
하루 거래량:
4.16M
Relative Volume:
1.22
시가총액:
$2.98B
수익:
$62.38M
순이익/손실:
$-101.59M
주가수익비율:
-24.16
EPS:
-0.8644
순현금흐름:
$-139.93M
1주 성능:
+11.78%
1개월 성능:
+65.32%
6개월 성능:
+161.98%
1년 성능:
+1,173%
1일 변동 폭
$19.60
$21.82
1주일 범위
$18.46
$21.82
52주 변동 폭
$1.03
$21.82
Tango Therapeutics Inc Stock (TNGX) Company Profile
명칭
Tango Therapeutics Inc
전화
(857) 320-4900
주소
201 BROOKLINE AVENUE, BOSTON
Compare TNGX vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
20.88 | 2.78B | 62.38M | -101.59M | -139.93M | -0.8644 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-23 | 개시 | Mizuho | Outperform |
| 2025-11-18 | 개시 | Wolfe Research | Peer Perform |
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-17 | 개시 | Jefferies | Buy |
| 2024-04-04 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-12 | 개시 | Piper Sandler | Overweight |
| 2023-12-08 | 개시 | B. Riley Securities | Buy |
| 2022-10-20 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | 개시 | SVB Leerink | Outperform |
모두보기
Tango Therapeutics Inc 주식(TNGX)의 최신 뉴스
TNGX: 93,000 shares from option exercise; Adam Crystal prior 10b5-1 sales (TNGX) - Stock Titan
Tango Therapeutics (NASDAQ:TNGX) Stock Price Up 9.3%Still a Buy? - MarketBeat
TNGX stock hits record high on inking collaboration deal with ERAS - MSN
Tango Therapeutics Ignites: 11% Surge to Historic Highs Signals Biotech Power Play - Bitget
Tango Therapeutics stock hits all-time high at 19.83 USD By Investing.com - Investing.com Canada
Tango Therapeutics (NASDAQ:TNGX) Reaches New 12-Month HighShould You Buy? - MarketBeat
Tango Therapeutics stock hits all-time high at 19.83 USD - Investing.com
Tango Therapeutics (TNGX) to Release Quarterly Earnings on Monday - MarketBeat
Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates - MSN
Trading Recap: How does Tango Therapeutics Inc correlate with Nasdaq2026 Analyst Calls & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Wall Street Zen Downgrades Tango Therapeutics (NASDAQ:TNGX) to Sell - MarketBeat
Tango Therapeutics (TNGX) sees cautious analyst optimism following earnings - MSN
Aug Levels: Will Tango Therapeutics Inc benefit from rising consumer demandSwing Trade & Real-Time Sentiment Analysis - baoquankhu1.vn
TNGX Technical Analysis & Stock Price Forecast - Intellectia AI
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology - GlobeNewswire Inc.
TNGX Stock Price, Quote & Chart | TANGO THERAPEUTICS INC (NASDAQ:TNGX) - ChartMill
Tango TherapeuticsFinancial Details - Crunchbase
Wall Street Analysts See a 46.07% Upside in Tango Therapeutics (TNGX): Can the Stock Really Move This High? - MSN
It Takes Two To TangoClinical Progress, Solid Balance Sheet Driving Momentum In TNGX - RTTNews
Can Tango Therapeutics Inc be recession proofMarket Trend Review & High Return Stock Watch Alerts - baoquankhu1.vn
Guidance Update: Can Tango Therapeutics Inc sustain earnings growth2026 Institutional Moves & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Guidance Update: Is Tango Therapeutics Inc undervalued by DCF analysis2026 Earnings Impact & Verified Technical Signals - baoquankhu1.vn
Tango Therapeutics stock hits 52-week high at $17.64 - Investing.com India
Tango Therapeutics stock hits 52-week high at $17.64 By Investing.com - Investing.com South Africa
Does Tango Therapeutics (TNGX) Trial Pact and ESOP Shelf Hint at a Pivotal Strategic Turn? - simplywall.st
Tango Therapeutics (NASDAQ:TNGX) Hits New 12-Month HighShould You Buy? - MarketBeat
Why Tango Therapeutics Stock Is Breaking Out Now - TipRanks
Farallon Capital Management LLC Buys 1,600,000 Shares of Tango Therapeutics, Inc. $TNGX - MarketBeat
Assessing Tango Therapeutics (TNGX) Valuation After Vopimetostat Progress And New Erasca Collaboration - simplywall.st
Tango Therapeutics, Inc. $TNGX Shares Sold by Trv Gp Iv LLC - MarketBeat
Avoro Capital Advisors LLC Takes $4.58 Million Position in Tango Therapeutics, Inc. $TNGX - MarketBeat
Tango Therapeutics (TNGX) Soars 52% on Buy Reco - MSN
Tango Therapeutics’ (TNGX) Sees Cautious Analyst Optimism Following Earnings - Insider Monkey
11 Best Day Trading Stocks to Buy Now - Insider Monkey
Tango Therapeutics Inc (TNGX) Stock News & Articles - 24/7 Wall St.
Mizuho Forecasts Strong Price Appreciation for Tango Therapeutics (NASDAQ:TNGX) Stock - MarketBeat
Stifel raises Tango Therapeutics stock price target on PRMT5 data - Investing.com Nigeria
Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX) - Bitget
10 Most Shorted Biotech Stocks to Buy According to Hedge Funds - Insider Monkey
Adam Crystal Sells 20,251 Shares of Tango Therapeutics (NASDAQ:TNGX) Stock - MarketBeat
Tango Therapeutics Insider Sold Shares Worth $303,765, According to a Recent SEC Filing - marketscreener.com
Insider sale: Tango Therapeutics (TNGX) R&D president sells shares - Stock Titan
X4 Pharmaceuticals, Immuneering and Tango Therapeutics Are Getting New Analyst Attention - 24/7 Wall St.
Is Erasca (ERAS) Quietly Reframing Its RAS Strategy With Tango’s Dual-Target Trial Collaboration? - Yahoo Finance
Tango Therapeutics (NASDAQ:TNGX) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Stifel raises Tango Therapeutics stock price target on PRMT5 data By Investing.com - Investing.com Australia
Tango Therapeutics (TNGX) Valuation Check After Strong Share Price Momentum And High P/S Multiple - Yahoo Finance
Tango Therapeutics Inc (TNGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):